Bupropion (Zyban, sustained-release tablets): update.
Dunlop
H
H
D016642:Bupropion / Q000009:adverse effects*; D002170:Canada; D018765:Dopamine Uptake Inhibitors / Q000009:adverse effects*; D006331:Heart Diseases / Q000139:chemically induced*; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced*; D012640:Seizures / Q000139:chemically induced*; D016540:Smoking Cessation
D018765:Dopamine Uptake Inhibitors; D016642:Bupropion